Biopharma Insights - page 19

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to deliver messenger RNA (mRNA) to the lungs. This innovative approach …

Continue ›››

AI-Powered Peptide Discovery from Plant Sources Leads to a Breakthrough In Muscle Recovery

Nuritas, an innovator in AI-based peptide discovery from natural sources, has announced the results of a second clinical trial on its patented ingredient, PeptiStrong™. The ingredient, which is sourced from …

Continue ›››

AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery

The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The success of these therapeutics has driven the pharma industry to …

Continue ›››

QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery

The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence (AI) methods that have accelerated the pace of research. With …

Continue ›››

Gandeeva Therapeutics and Moderna Join Forces to Explore AI-Enabled Cryo-EM Technology

Gandeeva Therapeutics, a precision medicine company specializing in designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, has announced a new research collaboration with Moderna …

Continue ›››

Portal Innovations Empowers Biotech Ventures in Chicago and Atlanta

Portal Innovations, headquartered in Chicago, is a biotech-focused venture capital company seeking to bolster the expansion of biotech startups in up-and-coming life sciences centers like Chicago and Atlanta. John Flavin, …

Continue ›››

MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology

As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This groundbreaking approach, which emerged in the early 2000s, involves the …

Continue ›››

AI Drug Discovery Financing Roundup: Unlearn.AI, Iktos, DenovAI, and More

The role of artificial intelligence (AI) in drug discovery is rapidly increasing, since it was shown to be able to expedite R&D process, reduce costs, and provide novel research insights …

Continue ›››

Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery

Oxford Drug Design, a biotechnology company with core expertise in computer-aided drug design, has announced that it has been engaged by PhoreMost Ltd (PhoreMost), a UK-based biopharmaceutical company dedicated to …

Continue ›››

The Potential of Artificial Intelligence to Transform the European Life Sciences Landscape (with a Caveat)

The adoption of artificial intelligence (AI) in life sciences has been rapidly expanding across the globe, and the European Union (EU) is no exception. With the increasing need for innovative …

Continue ›››

Altasciences Boosts Life-Saving Drug Development with Proscia's Digital Pathology Platform

In a strategic move to improve the drug development process, Altasciences has partnered with Proscia, a leading provider of digital and computational pathology solutions. The collaboration leverages Proscia's Concentriq® for …

Continue ›››

Proscia Enhances Preclinical R&D Platform: Streamlining Pathology Workflows for Faster Drug Safety Decisions

Proscia, a company specializing in digital and computational pathology solutions, recently announced updates to its preclinical research and development (R&D) offerings. These improvements target the company's flagship software platform, Concentriq® …

Continue ›››